Free Trial

SNDL (SNDL) Competitors

$2.22
+0.04 (+1.83%)
(As of 05/24/2024 04:00 PM ET)

SNDL vs. MTEX, HAPP, NAII, FOMX, TLRY, CRON, USNA, CGC, MNMD, and BTMD

Should you be buying SNDL stock or one of its competitors? The main competitors of SNDL include Mannatech (MTEX), Happiness Development Group (HAPP), Natural Alternatives International (NAII), Menlo Therapeutics (FOMX), Tilray (TLRY), Cronos Group (CRON), USANA Health Sciences (USNA), Canopy Growth (CGC), Mind Medicine (MindMed) (MNMD), and biote (BTMD).

SNDL vs.

Mannatech (NASDAQ:MTEX) and SNDL (NASDAQ:SNDL) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, community ranking, institutional ownership and profitability.

Mannatech has a net margin of -1.31% compared to Mannatech's net margin of -14.99%. Mannatech's return on equity of -9.98% beat SNDL's return on equity.

Company Net Margins Return on Equity Return on Assets
Mannatech-1.31% -15.37% -3.92%
SNDL -14.99%-9.98%-8.40%

In the previous week, Mannatech had 2 more articles in the media than SNDL. MarketBeat recorded 4 mentions for Mannatech and 2 mentions for SNDL. Mannatech's average media sentiment score of 0.75 beat SNDL's score of 0.69 indicating that SNDL is being referred to more favorably in the news media.

Company Overall Sentiment
Mannatech Positive
SNDL Positive

Mannatech has higher earnings, but lower revenue than SNDL. Mannatech is trading at a lower price-to-earnings ratio than SNDL, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mannatech$131.96M0.11-$2.24M-$0.89-8.61
SNDL$673.33MN/A-$127.91M-$0.40-5.55

13.0% of Mannatech shares are held by institutional investors. 41.5% of Mannatech shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Mannatech has a beta of 1.18, indicating that its share price is 18% more volatile than the S&P 500. Comparatively, SNDL has a beta of 3.28, indicating that its share price is 228% more volatile than the S&P 500.

SNDL has a consensus target price of $4.00, indicating a potential upside of 80.18%. Given Mannatech's higher probable upside, analysts clearly believe SNDL is more favorable than Mannatech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mannatech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
SNDL
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Mannatech received 144 more outperform votes than SNDL when rated by MarketBeat users. Likewise, 74.93% of users gave Mannatech an outperform vote while only 72.16% of users gave SNDL an outperform vote.

CompanyUnderperformOutperform
MannatechOutperform Votes
284
74.93%
Underperform Votes
95
25.07%
SNDLOutperform Votes
140
72.16%
Underperform Votes
54
27.84%

Summary

Mannatech and SNDL tied by winning 8 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNDL vs. The Competition

MetricSNDLMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market CapN/A$1.24B$4.98B$8.04B
Dividend YieldN/A2.61%2.80%3.96%
P/E Ratio-5.558.40179.2218.40
Price / SalesN/A9.322,541.7574.17
Price / CashN/A16.9132.5328.79
Price / Book0.361.974.934.40
Net Income-$127.91M-$161.13M$103.60M$213.46M
7 Day Performance-5.93%-1.70%-0.99%-0.96%
1 Month Performance10.45%-2.85%3.33%3.10%
1 Year Performance42.31%2.32%5.33%7.51%

SNDL Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MTEX
Mannatech
0.5751 of 5 stars
$7.66
flat
N/A-39.8%$14.44M$131.96M-8.61213Analyst Forecast
HAPP
Happiness Development Group
0 of 5 stars
$1.00
+12.4%
N/A-69.7%$31.30M$95.59M2.08215Gap Up
High Trading Volume
NAII
Natural Alternatives International
0 of 5 stars
$6.54
+0.6%
N/A-15.3%$40.55M$154.01M-11.68317Analyst Forecast
News Coverage
Gap Up
FOMX
Menlo Therapeutics
0 of 5 stars
$2.99
flat
N/AN/A$184.12M$3.60M-2.3080
TLRY
Tilray
1.5111 of 5 stars
$1.85
+1.1%
$2.71
+46.4%
-0.5%$1.43B$627.12M-4.201,600
CRON
Cronos Group
0.3416 of 5 stars
$2.64
flat
$3.00
+13.6%
+49.2%$1.01B$87.24M-17.60356
USNA
USANA Health Sciences
3.7644 of 5 stars
$46.71
-2.3%
$46.00
-1.5%
-25.6%$889.87M$921.01M14.551,800
CGC
Canopy Growth
0.6808 of 5 stars
$9.18
+0.8%
$4.87
-47.0%
+4.6%$772.62M$304.79M-0.611,621Upcoming Earnings
MNMD
Mind Medicine (MindMed)
2.7404 of 5 stars
$8.23
+3.5%
$17.67
+114.7%
+132.8%$578.31MN/A-2.8057
BTMD
biote
2.3416 of 5 stars
$6.35
+7.6%
$8.11
+27.7%
+17.6%$393.93M$185.36M57.73194Positive News

Related Companies and Tools

This page (NASDAQ:SNDL) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners